It was shown that the transcript levels of TLR3 were overexpressed in the nasopharyngeal epithelial cells of COVID-19 patients with clinical symptoms compared with controls [100], and that a lower peripheral blood TLR3 expression was associated with an unfavorable outcome in severe COVID-19 patients [101]. Here, TLR3 is linked to COVID-19.